QuidelOrtho Corporation Registered Shs News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

10.12.24	QuidelOrtho Announces Appointment of Two Independent Directors to its Board (Businesswire)
20.11.24	QuidelOrtho Corporation Announces Pricing of Secondary Offering of Common Stock by the Carlyle Group (Businesswire)
19.11.24	QuidelOrtho Corporation Announces Secondary Offering of Common Stock by the Carlyle Group (Businesswire)
28.10.24	QuidelOrtho to Participate in Three Upcoming Investor Conferences (Businesswire)
17.10.24	QuidelOrtho to Report Third Quarter 2024 Financial Results (Businesswire)
09.10.24	QuidelOrtho Announces New R&D Executive Leader (Businesswire)
10.09.24	QuidelOrtho Appoints Lee Bowman as Chief Human Resources Officer (Businesswire)
29.08.24	VITROS® Syphilis Assay Now Available on VITROS 3600 Immunodiagnostic System, VITROS 5600 and VITROS XT 7600 Integrated Systems in the U.S. (Businesswire)
19.08.24	QuidelOrtho to Participate in Upcoming Investor Conferences (Businesswire)
17.07.24	QuidelOrtho to Report Second Quarter 2024 Financial Results (Businesswire)
23.05.24	QuidelOrtho to Participate in 44th Annual William Blair Growth Stock Conference (Businesswire)
15.05.24	QuidelOrtho Opens New Distribution Center in Pedricktown, NJ (Businesswire)
08.05.24	QuidelOrtho Reports First Quarter 2024 Financial Results (Businesswire)
02.05.24	QuidelOrtho Appoints Brian J. Blaser as President and Chief Executive Officer (Businesswire)
17.04.24	QuidelOrtho To Report First Quarter 2024 Financial Results (Businesswire)
10.04.24	QuidelOrtho Adds Fentanyl Test to Its Vitros® Systems as a MicroTip® Partnership Assay (Businesswire)
02.04.24	QuidelOrtho Receives FDA 510(k) Clearance for Its QuickVue® COVID-19 Test (Businesswire)
06.03.24	QuidelOrtho Receives Health Canada Approval for Quidel® Triage® PLGF Test for Laboratory Use in Canada (Businesswire)
26.02.24	QuidelOrtho to Participate in 45th Annual Raymond James Institutional Investor Conference (Businesswire)
21.02.24	QuidelOrtho Announces Changes in Executive Leadership (Businesswire)
23.01.24	QuidelOrtho to Report Fourth Quarter and Full-year 2023 Financial Results (Businesswire)
22.12.23	QuidelOrtho to Present at 42nd Annual J.P. Morgan Healthcare Conference (Businesswire)
20.12.23	QuidelOrtho Receives 510(K) Clearance for Savanna® Multiplex Molecular Platform and Savanna® HSV 1+2/VZV PCR Assay (Businesswire)
16.11.23	QuidelOrtho to Participate in the Evercore ISI Conference (Businesswire)
12.10.23	QuidelOrtho Reports Preliminary Revenue Results for the Third Quarter 2023 (Businesswire)
21.09.23	QuidelOrtho Receives CLIA Waiver for Sofia® 2 SARS Antigen+ FIA (Businesswire)
28.08.23	QuidelOrtho to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference (Businesswire)
25.07.23	QuidelOrtho Ranks No. 1 in Customer Satisfaction for Six Years in a Row (Businesswire)
24.07.23	QuidelOrtho Partners With BYG4lab® to Strengthen Informatics Offerings (Businesswire)
18.07.23	QuidelOrtho to Report Second Quarter 2023 Financial Results (Businesswire)
23.05.23	QuidelOrtho to Participate in William Blair 43rd Annual Growth Stock Conference (Businesswire)
03.05.23	QuidelOrtho Reports First Quarter 2023 Financial Results (Businesswire)
13.04.23	QuidelOrtho Reports Preliminary Revenue Results for the First Quarter 2023 (Businesswire)
28.03.23	QuidelOrtho Announces the Formation of the International QuidelOrtho Women’s Leadership Network (QWLN) (Businesswire)
08.03.23	QuidelOrtho Receives De Novo FDA Authorization for Sofia® 2 SARS Antigen+ FIA (Businesswire)
02.03.23	QuidelOrtho to Participate in the Raymond James 44th Annual Institutional Investor Conference (Businesswire)
06.01.23	QuidelOrtho Reports Preliminary Revenue Results for Fourth Quarter and Full Year 2022 (Businesswire)
28.12.22	QuidelOrtho to Present at the J.P. Morgan Healthcare Conference (Businesswire)
19.12.22	Health Canada Grants License for Quidel® TriageTrue® High-Sensitivity Troponin I Test to Aid in the Diagnosis of Myocardial Infarction (Businesswire)
16.12.22	QuidelOrtho and Runda Medical Form Joint Venture to Develop and Manufacture Assays for VITROS® Platform (Businesswire)
12.12.22	QuidelOrtho Announces Separation of Chairman and Chief Executive Officer Roles (Businesswire)
30.11.22	QuidelOrtho to Host Investor Day on December 13, 2022 (Businesswire)
12.10.22	QuidelOrtho Reports Preliminary Revenue Results for Third Quarter 2022 (Businesswire)
06.09.22	QuidelOrtho to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference (Businesswire)
01.09.22	Quidel and World Champion Los Angeles Rams Partner to Combat COVID-19 and Promote Health Awareness in the L.A. Community (Businesswire)
17.08.22	QuidelOrtho Announces $300 Million Share Repurchase Authorization (Businesswire)
04.08.22	QuidelOrtho Reports Second Quarter 2022 Financial Results (Businesswire)
22.06.22	Quidel Corporation and the American Heart Association join forces to Advance Education and Awareness of Heart Disease in San Diego County (Businesswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Givaudan	4’040.00	1.71 %	K V
Geberit	547.80	1.59 %	K V
Part Grp Hldg	1’297.00	1.49 %	K V
ABB	51.94	1.29 %	K V
Swiss Life Hldg	691.80	1.26 %	K V
Zurich Insur Gr	548.00	-0.18 %	K V
Kuehne+Nagel Int	210.90	-0.33 %	K V
Swiss Re	128.20	-0.66 %	K V
Sonova Hldg	293.00	-0.85 %	K V
Novartis	87.94	-0.92 %	K V

Nachrichten zu QuidelOrtho Corporation Registered Shs

Aktien Top/Flop

Meistgelesene Nachrichten